FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 3905720 · Received July 1, 2014

Report

Report Number
2124215-2014-11236
Event Type
Injury
Date Received
July 1, 2014
Date of Event
April 23, 2013
Report Date
May 20, 2014
Manufacturer
CPI - DEL CARIBE
Product Code
LWS
PMA / PMN Number
P910073
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT REMOTE MONITORING OF THIS DEVICE AND RIGHT VENTRICULAR LEAD REVEALED A HIGH OUT OF RANGE PACING IMPEDANCE MEASUREMENT. THIS INFORMATION HAS BEEN PROVIDED TO THE PHYSICIAN AND IS BEING FURTHER MONITORED. ALL OTHER MEASUREMENTS WERE NORMAL. NO ADVERSE PATIENT EFFECTS WERE REPORTED. APPROXIMATELY, ONE YEAR LATER, A REPLACEMENT PROCEDURE WAS PERFORMED. THE RIGHT VENTRICULAR LEAD WAS SURGICALLY ABANDONED AND REPLACED DUE TO NOISE AND THE OUT OF RANGE IMPEDANCE MEASUREMENT. IN ADDITION, INCREASED THRESHOLD MEASUREMENTS WERE OBSERVED. THE PATIENT HAS NOT RECEIVED ANY INAPPROPRIATE SHOCKS. NO PACING INHIBITION WAS REPORTED AS A RESULT OF THIS ISSUE AS THE PATIENT IS PACEMAKER DEPENDENT. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
384664 ENDOTAK RELIANCE IMPLANTABLE LEAD LWS CPI - DEL CARIBE 0185

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| L| R 0185| F102